Maria Elena Maccari
Senior author studying primary immunodeficiencies and their treatment
Institute for Immunodeficiency, Center for Chronic Immunodeficiency, Medical Center – University of Freiburg, Germany
Maria Elena Maccari works at the Institute for Immunodeficiency, Center for Chronic Immunodeficiency, at the University of Freiburg Medical Center, and in the pediatric hematology-oncology and stem cell transplantation division of Freiburg's Children's Hospital.
Senior author of a 2026 ESID registry-based analysis of 95 patients with Activated PI3-Kinase-δ Syndrome, comparing rapamycin against the newer targeted inhibitor leniolisib in real-world clinical practice.
Milestones in the Atlas
| Year | Evidence | Study |
|---|---|---|
| 2026 | H | Leniolisib and rapamycin in Activated PI3-Kinase-δ-syndrome: a retrospective ESID registry-based analysis RIV2026 Senior author: real-world ESID registry analysis of rapamycin vs. leniolisib in Activated PI3Kδ Syndrome. |
Co-authors in the Atlas
People with a profile here who share at least one study with Maria Elena Maccari.
- Beatrice Rivalta First author of a multicenter registry analysis comparing rapamycin and leniolisib in a rare immune disorder